Epiretinal membranes indicate a severe phenotype of neurofibromatosis type 2

Retina

Volumn 30, Issue 4 SUPPL. 4, 2010, Pages

  Sisk, Robert A ^a   Berrocal, Audina M ^a   Schefler, Amy C ^a   Dubovy, Sander R ^a   Bauer, Mislen S ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Epiretinal membranes; Genetic diseases; Neurofibromatosis; Optical coherence tomography; Pediatric retinal diseases

Indexed keywords

ANAMNESIS; BIOMICROSCOPY; CASE REPORT; CHILD; CONFERENCE PAPER; EPIRETINAL MEMBRANE; FEMALE; GAMMA KNIFE RADIOSURGERY; HAMARTOMA; HUMAN; MALE; MULTIPLE CANCER; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PIGMENT EPITHELIUM; PRESCHOOL CHILD; RETINA INJURY; SCHOOL CHILD; VISUAL ACUITY; VITREOUS BODY DETACHMENT;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPIRETINAL MEMBRANE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 2; NEUROSURGICAL PROCEDURES; PHENOTYPE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 77951037664     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181dc58bf     Document Type: Conference Paper

References (23)

1. Okada T, You L, Giancotti FG. Shedding light on Merlin's wizardry. Trends Cell Biol 2007;17:222-229.
2. Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I: Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-846.
3. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG. Evaluation of clinical diagnostic criteria for neurofibromatosis
4. Neurology 2006;59:1759-1765.
5. Kluwe L, Mautner V, Heinrich B, et al. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 2003;40:109-114.
6. Parry DM, MacCollin MM, Kaiser-Kupfer MI, et al. Germline mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 1996;59:529-539.
7. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-461.
8. Kaye LD, Rothner A, Beauchamp GR, et al. Ocular findings associated with neurofibromatosis type II. Ophthalmology 1992;99:1424-1429.
9. Evans DGR, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 1999;81:496-499.
10. Baser ME, Kuramoto L, Joe H, et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet 2004;75:231-239.
11. Schefler AC, Dubovy SR, Berrocal AM. Optical coherence tomography of epiretinal membranes in neurofibromatosis 2. Ophthalmic Surg Lasers Imaging 2008;39:73-77.
12. Meyers SM, Gutman FA, Kaye LD, Rothner AD. Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 1995;93:245-257.
13. Bosch MM, Boltshauser E, Harpes P, Landau K. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 2006;141:1068-1077.
14. Ruttledge MH, Andermann AA, Phelan CM, et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996;59:331-342.
15. Baser ME, Friedman M, Aeschliman D, et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 2002;71:715-723.
16. Evans DG, Trueman L, Wallace A, Collins S, Strachan T. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998;35:450-455.
17. Kluwe L, Beyer S, Baser ME, et al. Identification of NF2 germ-line mutations and comparison with NF2 phenotypes. Hum Genet 1996;98:534-538.
18. McLaughlin ME, Pepin SM, MacCollin M, Choopong P, Lessell S. Ocular pathologic findings of neurofibromatosis type 2. Arch Ophthalmol 2007;125:389-394.
19. Song BJ, Ko MK, Choe JK. Ultrastructural change of the Müller cell in the culture of sensory retina. Korean J Ophthalmol 1995;9:84-88.
20. Laqua H, Wessing A. Congenital retino-pigment epithelial malformation, previously described as hamartomas. Mod Probl Ophthalmol 1979;20:101-106.
21. Shields CL, Mashayekhi A, Dai VV, Materin MA, Shields JA. Optical coherence tomography findings of combined hamartoma of the retina and retinal pigment epithelium in 11 patients. Arch Ophthalmol 2005;123:1746-1750.
22. MacDonald HR, Abrams GW, Burke JM, Neuwirth J. Clinicopathologic results of vitreous surgery for epiretinal membranes in patients with combined retinal and retinal pigment epithelial hamartomas. Am J Ophthalmol 1985;100:806-813.
23. Rich KA, Figueroa SL, Zhan Y, Blanks JC. Effects of Müller cell disruption on mouse photoreceptor cell development. Exp Eye Res 1995;61:235-248.